PROFILPELAJAR.COM

Rodney Sinclair

Rodney Sinclair
Other namesRodney D. Sinclair; Rodney Daniel Sinclair
OccupationsDermatologist, scientific researcher
Known forHair loss research, low-dose oral minoxidil, sublingual minoxidil
Websitewww.sinclairdermatology.com.au/team/prof-rod-sinclair/

Rodney Sinclair is an Australian dermatologist and scientific researcher specializing in the study and treatment of alopecia (hair loss) and inflammatory skin diseases.[1][2][3] His affiliations include the University of Melbourne, St. Vincent's Hospital, Epworth Hospital, and the Sinclair Dermatology Institute for Research, among others.[1][2][3][4] He is responsible for the Sinclair scale hair loss grading system.[1] In addition, Sinclair was responsible for the emergence of low-dose oral minoxidil (LDOM) for treatment of hair loss starting in 2015 with his publications in this area.[5][4][2][6][7][8][9] He is also the founder and director of Samson Clinical, which is developing sublingual minoxidil (SLM) for hair loss.[10][11][12] Sinclair has written 7 textbooks in the area of dermatology and published more than 500 research articles.[1][3]

References

  1. ^ a b c d Farjo, Nilofer; Sinclair, Rod; Rufaut, Nick (2009). "Hair Sciences: An interview with Dr. Rodney Sinclair on female pattern hair loss". International Society of Hair Restoration Surgery. 19 (1): 27–29. doi:10.33589/19.1.0027. ISSN 2641-6719.
  2. ^ a b c Sheppeard, Amanda (8 June 2022). "Meet the founding editor of Dermatology Republic". Dermatology Republic. Retrieved 5 April 2026.
  3. ^ a b c "Rodney Sinclair". The Conversation. 16 February 2022. Retrieved 5 April 2026.
  4. ^ a b Wootton, Hannah (6 October 2022). "Hair loss: Australian researcher Rodney Sinclair's new treatment". Australian Financial Review. Retrieved 5 April 2026.
  5. ^ Kolata G (August 18, 2022). "An Old Medicine Grows New Hair for Pennies a Day, Doctors Say". The New York Times. Archived from the original on August 19, 2022.
  6. ^ Rodney Sinclair (16 May 2015). Female pattern hair loss: Combination therapy with low dose oral minoxidil and spironolactone. 2015 Annual Meeting of the Australasian Society for Dermatology Research.
  7. ^ Rodney D. Sinclair (21 November 2015). Female Pattern Hair Loss: Combination Therapy With Low Dose Oral Minoxidil and Spironolactone (PDF). 9th World Congress for Hair Research, November 18-21, 2015, Miami, Florida, USA.
  8. ^ Yang X, Thai KE (November 2016). "Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil". Australas J Dermatol. 57 (4): e130–e132. doi:10.1111/ajd.12350. PMID 25966934.
  9. ^ Sinclair R (May 2016). "Treatment of monilethrix with oral minoxidil". JAAD Case Rep. 2 (3): 212–215. doi:10.1016/j.jdcr.2016.02.011. PMC 4887583. PMID 27284572.
  10. ^ Dias FR, Yong SS, FitzGerald H, Sinclair RD, Bhoyrul B (2025). "Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations". Front Pharmacol. 16 1718208. doi:10.3389/fphar.2025.1718208. PMC 12898826. PMID 41695992.
  11. ^ Debbarma, Salong (17 November 2025). "Samson Clinical concludes enrolment for Phase III AGA trial". Clinical Trials Arena. Retrieved 5 April 2026.
  12. ^ "Sublingual minoxidil". AdisInsight. 24 November 2025. Retrieved 5 April 2026.


Stub icon 1 Stub icon 2

This biographical article related to medicine in Australia is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.